The development of global vaccine stockpiles

The Lancet Infectious Diseases

Volumn 15, Issue 3, 2015, Pages 340-347

  Yen, Catherine ^a   Hyde, Terri B ^a   Costa, Alejandro J ^b   Fernandez, Katya ^b   Tam, John S ^b   Hugonnet, Stéphane ^b   Huvos, Anne M ^b   Duclos, Philippe ^b   Dietz, Vance J ^a   Burkholder, Brenton T ^c  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

^c Natl Salmonella and Shigella Centre   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLERA VACCINE; INFLUENZA VACCINE; MENINGOCOCCUS VACCINE; SMALLPOX VACCINE; VACCINE; YELLOW FEVER VACCINE;

CLINICAL FEATURE; DISEASE COURSE; DISEASES; ETHICAL DECISION MAKING; FUNDING; FUTUROLOGY; HEALTH; HEALTH CARE PLANNING; HUMAN; INFECTION PREVENTION; MONITORING; PREDICTION; PRIORITY JOURNAL; REVIEW; VACCINATION; VACCINE PRODUCTION; COMMUNICABLE DISEASES, EMERGING; INFECTION CONTROL; PROCEDURES; SUPPLY AND DISTRIBUTION;

COMMUNICABLE DISEASE CONTROL; COMMUNICABLE DISEASES, EMERGING; GLOBAL HEALTH; HUMANS; STRATEGIC STOCKPILE; VACCINES;

EID: 84923261767     PISSN: 14733099     EISSN: 14744457     Source Type: Journal    
DOI: 10.1016/S1473-3099(14)70999-5     Document Type: Review

References (43)

1. Nelson CB, Birmingham M, Costa A, et al. Preparedness for infectious threats: public-private partnership to develop an affordable vaccine for an emergent threat: the trivalent Neisseria meningitidis ACW135 polysaccharide vaccine. Am J Public Health 2007, 97(suppl 1):S15-S22.
2. WHO Technical Working Group on creation of an oral cholera vaccine stockpile: meeting report 2012, WHO, World Health Organization, Geneva.
3. Arita I Smallpox vaccine and its stockpile in 2005. Lancet Infect Dis 2005, 5:647-652.
4. Lane KS, Chu SY, Santoli JM The United States pediatric vaccine stockpile program. Clin Infect Dis 2006, 42(suppl 3):S125-S129.
5. Milstien J, Lambert S Emergency response vaccines--a challenge for the public sector and the vaccine industry. Vaccine 2002, 21:146-154.
6. Costa A. Yellow fever and meningococcal vaccine stockpiles. Oral cholera vaccine stockpile meeting. Geneva, Switzerland; 2011.
7. Response to epidemic meningitis in Africa, 1997. Wkly Epidemiol Rec 1997, 72:313-318. WHO.
8. Yellow fever-technical consensus meeting. Geneva, 2-3 March 1998 1998, WHO, World Health Organization, Geneva.
9. Meeting of the Strategic Advisory Group of Experts on immunization, November 2013-conclusions and recommendations. Wkly Epidemiol Rec 2014, 89:1-20. WHO.
10. Resolution 60.28 - Pandemic influenza preparedness: sharing of influenza viruses and access to vaccines and other benefits. Sixtieth World Health Assembly. Geneva, 14-23 May 2007. Resolutions and decisions 2007, World Health Assembly, World Health Organization, Geneva.
11. Yellow Fever Initiative: providing an opportunity of a lifetime 2010, WHO, UNICEFUNICEF, World Health Organization, Geneva, (accessed Oct 13, 2011). http://www.who.int/csr/disease/yellowfev/YFIbrochure.pdf?ua=1.
12. Klein JO, Myers MG Vaccine shortages: why they occur and what needs to be done to strengthen vaccine supply. Pediatrics 2006, 117:2269-2275.
13. The global eradication of smallpox: final report of the Global Commission for the Certification of Smallpox Eradication 1979, WHO, World Health Organization, Geneva.
14. Report of the meeting of the ad hoc committee on orthopoxvirus infections. Geneva, Switzerland. 31 August-1 September 2004 2004, WHO, World Health Organization, Geneva.
15. Smith BT, Inglesby TV, Brimmer E, et al. Navigating the storm: report and recommendations from the Atlantic Storm exercise. Biosecur Bioterror 2005, 3:256-267.
16. Ramakrishnan M, Ulland AJ, Steinhardt LC, Moïsi JC, Were F, Levine OS Sequelae due to bacterial meningitis among African children: a systematic literature review. BMC Med 2009, 7:47.
17. Stephens DS, Greenwood B, Brandtzaeg P Epidemic meningitis, meningococcaemia, and Neisseria meningitidis. Lancet 2007, 369:2196-2210.
18. Meningococcal vaccines: WHO position paper, November 2011. Wkly Epidemiol Rec 2011, 86:521-539. WHO.
19. Greenwood B Manson Lecture. Meningococcal meningitis in Africa. Trans R Soc Trop Med Hyg 1999, 93:341-353.
20. Käyhty H, Karanko V, Peltola H, Sarna S, Mäkelä PH Serum antibodies to capsular polysaccharide vaccine of group A Neissera meningitidis followed for three years in infants and children. J Infect Dis 1980, 142:861-868.
21. Reingold AL, Broome CV, Hightower AW, et al. Age-specific differences in duration of clinical protection after vaccination with meningococcal polysaccharide A vaccine. Lancet 1985, 2:114-118.
22. Guidelines for applying to the emergency stockpile 2008, International Coordinating Group on Vaccine Provision for Epidemic Meningitis Control, World Health Organization, Geneva.
23. Fernandez KA, Costa A. Building partnerships to improve outbreak preparedness: the establishment of an emergency vaccine stockpile for meningitis epidemics. International Conference on Emerging Infectious Diseases; Atlanta, GA, USA; March 16-19, 2008. Board 46.
24. Meningitis in Chad, Niger and Nigeria: 2009 epidemic season. Wkly Epidemiol Rec 2010, 85:47-63. WHO.
25. Meningitis in Burkina Faso, Chad, Niger, Nigeria and Ghana: 2010 epidemic season. Wkly Epidemiol Rec 2011, 86:143-151. WHO.
26. Meningococcal disease in countries of the African meningitis belt, 2012 - emerging needs and future perspectives. Wkly Epidemiol Rec 2013, 88:129-136. WHO.
27. Vaccines and vaccination against yellow fever. WHO position paper-June 2013. Wkly Epidemiol Rec 2013, 88:269-283. WHO.
28. Ali M, Lopez AL, You YA, et al. The global burden of cholera. Bull World Health Organ 2012, 90:209-218.
29. Resolution 64.18 - Cholera: mechanisms for control and prevention. Sixty-fourth World Health Assembly 2011, World Health Assembly, World Health Organization, Geneva.
30. Meeting of the Immunization Strategic Advisory Group of Experts, November 2007-conclusions and recommendations. Wkly Epidemiol Rec 2008, 83:1-15. WHO.
31. The Global Action Plan to increase supply of pandemic influenza vaccines. Report of the second meeting of the Advisory Group. Pune, Maharashtra, India 26 November 2008 2009, WHO, World Health Organization, Geneva.
32. Miller E Report from the SAGE working group on influenza vaccines and immunizations. SAGE Meeting; Geneva; July 12-14, 2011 (accessed Oct 25, 2014). http://www.who.int/influenza_vaccines_plan/resources/lmiller.pdf.
33. Pandemic influenza preparedness framework for the sharing of influenza viruses and access to vaccines and other benefits 2011, WHO, World Health Organization, Geneva.
34. Briand S Some lessons learned from other vaccine stockpiles. Informal Consultation on Technical Specifications for a (WHO) International H5N1 Vaccine Stockpile; Geneva; Oct 17-18, 2007 (accessed July 28, 2011). http://www.who.int/biologicals/areas/vaccines/influenza/influenza_mtg_17-18_October_2007/en/index1.html.
35. Detecting meningococcal meningitis epidemics in highly-endemic African countries. Wkly Epidemiol Rec 2000, 75:306-309. WHO.
36. Report of the WHO pandemic influenza A(H1N1) vaccine deployment initiative 2012, WHO, World Health Organization, Geneva.
37. Dellepiane N, Wood D Twenty-five years of the WHO vaccines prequalification programme (1987-2012): lessons learned and future perspectives. Vaccine 2013, published online Dec 2. 10.1016/j.vaccine.2013.11.066.
38. Maskery B, DeRoeck D, Levin A, Kim YE, Wierzba TF, Clemens JD Strategy, demand, management, and costs of an international cholera vaccine stockpile. J Infect Dis 2013, 208(suppl 1):S15-S22.
39. Milstien J Emergency response vaccines: lessons learned in response to communicable diseases. Expert Opin Biol Ther 2003, 3:1121-1131.
40. Nathan N, Barry M, Van Herp M, Zeller H Shortage of vaccines during a yellow fever outbreak in Guinea. Lancet 2001, 358:2129-2130.
41. Guidance on development and implementation of a national deployment and vaccination plan for pandemic influenza vaccines 2012, WHO, World Health Organization, Geneva.
42. Vaccination in acute humanitarian emergencies: a framework for decision making 2013, Strategic Advisory Group of Experts on Immunization Working Group on Vaccination in Humanitarian Emergencies, World Health Organization, Geneva.
43. Moodley K, Hardie K, Selgelid MJ, et al. Ethical considerations for vaccination programmes in acute humanitarian emergencies. Bull World Health Organ 2013, 91:290-297.